Markets
Lipocine stock tumbles after phase 3 trial misses endpoint
Lipocine stock tumbles after phase 3 trial misses endpoint
Top movers
All news
Markets1513 stories
Markets
Equities, indices, macro moves, and market structure from our syndicated feeds.
MarketsWhich global stocks offer high-quality dividends with low cut risk?
Which global stocks offer high-quality dividends with low cut risk?
MarketsStock Markets Correct to the Downside Overnight
Stock Markets Correct to the Downside Overnight
MarketsBlue Owl limits withdrawals in two funds as investors flee
Blue Owl limits withdrawals in two funds as investors flee
MarketsSaudi Arabia stocks lower at close of trade; Tadawul All Share down 0.07%
Saudi Arabia stocks lower at close of trade; Tadawul All Share down 0.07%
MarketsAnalysis-US defense stocks see no Iran war lift after early surge
Analysis-US defense stocks see no Iran war lift after early surge
MarketsBlue Owl Capital stock falls after limiting fund redemptions
Blue Owl Capital stock falls after limiting fund redemptions
MarketsRivian beats quarterly delivery estimates as EV demand stabilizes
Rivian beats quarterly delivery estimates as EV demand stabilizes
MarketsBed Bath & Beyond stock gains on Container Store acquisition
Bed Bath & Beyond stock gains on Container Store acquisition
- Markets
TSX set to open lower after Trump signals escalation in Iran conflict
TSX set to open lower after Trump signals escalation in Iran conflict
- Markets
Forward Air After the Merger: Dislocation or Structural Impairment?
Forward Air After the Merger: Dislocation or Structural Impairment?
- Markets
The Replacement Economics Behind Kirby Corporation’s Inland Marine Advantage
The Replacement Economics Behind Kirby Corporation’s Inland Marine Advantage